This article is more than 5 years old. Information may no longer be current.

Xtant Medical receives expanded patent for demineralized bone matrices

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Xtant Medical announced their subsidiary, Bacterin International, has received a U.S. patent for demineralized bone matrices derived from cortical bone. The patent will include Bacterin’s OsteoSTX, OsteoWrap and OrbitalWrap HD product lines.

The company has other domestic patents pending to cover aspects of their allograft processing and demineralization technologies, according to a company press release.

“This patent adds to the growing body of evidence substantiating the superior processing methodologies associated with Bacterin's allograft portfolio,” Gregory Juda, MD, chief scientific officer for Bacterin, stated in the release.

Reference: www.xtantmedical.com